Trial Profile
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Doses of IDEA-033 in Comparison to Oral Naproxen for the Treatment of the Signs and Symptoms of Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2012
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 09 Jun 2012 Primary endpoints 'Western-Ontario-and-McMaster-Universities-Osteoarthritis-Index' and 'Global-Response-Assessment' have not been met according to results presented at the 13th Annual Congress of the European League Against Rheumatism.
- 09 Jun 2012 Results presented at the 13th Annual Congress of the European League Against Rheumatism.
- 15 Nov 2006 New trial record.